$CDZI
CADIZ INC

2020 Q3 Form 10-Q Financial Statement

#000143774920017083 Filed on August 07, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2020 Q2 2019 Q2
Revenue $139.0K $148.0K $111.0K
YoY Change 26.36% 33.33% 1.83%
Cost Of Revenue
YoY Change
Gross Profit $111.0K
YoY Change 1.83%
Gross Profit Margin 100.0%
Selling, General & Admin $2.530M $3.100M $3.290M
YoY Change -15.67% -5.78% 43.04%
% of Gross Profit 2963.96%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $100.0K $100.0K $60.00K
YoY Change 42.86% 66.67% 0.0%
% of Gross Profit 54.05%
Operating Expenses $2.630M $3.190M $3.350M
YoY Change -14.33% -4.78% 41.95%
Operating Profit -$2.494M -$3.046M -$3.240M
YoY Change -15.63% -5.99% 43.68%
Interest Expense $1.920M $1.674M $4.303M
YoY Change -56.05% -61.1% 12.59%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$4.414M -$4.719M -$7.474M
YoY Change -39.18% -36.86% 23.97%
Income Tax $2.000K $1.000K $2.000K
% Of Pretax Income
Net Earnings -$4.493M -$4.793M -$7.476M
YoY Change -39.64% -35.89% 23.94%
Net Earnings / Revenue -3232.37% -3238.51% -6735.14%
Basic Earnings Per Share
Diluted Earnings Per Share -$128.1K -$137.6K -$282.5K
COMMON SHARES
Basic Shares Outstanding 34.80M 34.80M
Diluted Shares Outstanding 35.04K 34.80K 26.48K

Balance Sheet

Concept 2020 Q3 2020 Q2 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.500M $5.600M $19.50M
YoY Change -50.98% -71.28% -3.47%
Cash & Equivalents $7.502M $5.568M $19.48M
Short-Term Investments
Other Short-Term Assets $600.0K $600.0K $600.0K
YoY Change 20.0% 0.0% 0.0%
Inventory
Prepaid Expenses
Receivables $96.00K $138.0K $108.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $8.233M $6.335M $20.16M
YoY Change -48.18% -68.58% -3.75%
LONG-TERM ASSETS
Property, Plant & Equipment $52.68M $52.45M $47.36M
YoY Change 10.7% 10.75% 2.91%
Goodwill $3.813M $3.813M $3.813M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $2.347M $1.998M
YoY Change 3205.63%
Other Assets $4.299M $4.339M $4.196M
YoY Change 3.42% 3.41% 6.77%
Total Long-Term Assets $65.14M $64.60M $57.37M
YoY Change 13.03% 12.61% 6.7%
TOTAL ASSETS
Total Short-Term Assets $8.233M $6.335M $20.16M
Total Long-Term Assets $65.14M $64.60M $57.37M
Total Assets $73.37M $70.93M $77.53M
YoY Change -0.2% -8.51% 3.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $438.0K $1.075M $1.086M
YoY Change -34.23% -1.01% 67.33%
Accrued Expenses $863.0K $1.026M $1.369M
YoY Change -6.9% -25.05% 40.84%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $54.00K $17.00K $53.00K
YoY Change 28.57% -67.92% -7.02%
Total Short-Term Liabilities $3.108M $4.190M $3.474M
YoY Change 19.49% 20.61% 8.36%
LONG-TERM LIABILITIES
Long-Term Debt $75.23M $73.74M $138.0M
YoY Change -46.8% -46.56% 6.2%
Other Long-Term Liabilities $0.00 $2.000K $15.80M
YoY Change -100.0% -99.99% 829.41%
Total Long-Term Liabilities $75.23M $73.74M $138.0M
YoY Change -46.81% -46.56% 6.2%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.108M $4.190M $3.474M
Total Long-Term Liabilities $75.23M $73.74M $138.0M
Total Liabilities $95.89M $95.11M $157.3M
YoY Change -40.13% -39.53% 5.82%
SHAREHOLDERS EQUITY
Retained Earnings -$531.4M -$526.9M -$486.8M
YoY Change 7.52% 8.24% 6.82%
Common Stock $353.0K $347.0K $269.0K
YoY Change 30.74% 29.0% 10.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$22.52M -$24.18M -$79.77M
YoY Change
Total Liabilities & Shareholders Equity $73.37M $70.93M $77.53M
YoY Change -0.2% -8.51% 3.77%

Cashflow Statement

Concept 2020 Q3 2020 Q2 2019 Q2
OPERATING ACTIVITIES
Net Income -$4.493M -$4.793M -$7.476M
YoY Change -39.64% -35.89% 23.94%
Depreciation, Depletion And Amortization $100.0K $100.0K $60.00K
YoY Change 42.86% 66.67% 0.0%
Cash From Operating Activities -$3.280M -$2.640M -$2.830M
YoY Change -14.36% -6.71% 14.11%
INVESTING ACTIVITIES
Capital Expenditures -$390.0K -$1.260M -$650.0K
YoY Change -36.07% 93.85% 51.16%
Acquisitions
YoY Change
Other Investing Activities -$430.0K -$1.040M
YoY Change
Cash From Investing Activities -$810.0K -$2.310M -$650.0K
YoY Change 32.79% 255.38% 51.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 6.030M -10.00K 6.730M
YoY Change 2412.5% -100.15% -53.78%
NET CHANGE
Cash From Operating Activities -3.280M -2.640M -2.830M
Cash From Investing Activities -810.0K -2.310M -650.0K
Cash From Financing Activities 6.030M -10.00K 6.730M
Net Change In Cash 1.940M -4.960M 3.250M
YoY Change -146.19% -252.62% -72.1%
FREE CASH FLOW
Cash From Operating Activities -$3.280M -$2.640M -$2.830M
Capital Expenditures -$390.0K -$1.260M -$650.0K
Free Cash Flow -$2.890M -$1.380M -$2.180M
YoY Change -10.25% -36.7% 6.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34799510
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Assets Current
AssetsCurrent
16117000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
52447000 USD
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
32955
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25906
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5568000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15682000 USD
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
138000 USD
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
28480567
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0 USD
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-73000 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4793000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-7476000 USD
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.14
CY2020Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2020Q2 us-gaap Revenues
Revenues
148000 USD
CY2019Q2 us-gaap Revenues
Revenues
111000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3098000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3285000 USD
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
96000 USD
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
70000000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34797062
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34797062
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28480567
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
66000 USD
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
3194000 USD
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
3351000 USD
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3046000 USD
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3240000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
1674000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
4303000 USD
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
1000 USD
CY2019Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
69000 USD
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4719000 USD
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-7474000 USD
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1000 USD
CY2019Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34798
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26479
us-gaap Revenues
Revenues
262000 USD
us-gaap Revenues
Revenues
220000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7075000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6209000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
175000 USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
132000 USD
us-gaap Costs And Expenses
CostsAndExpenses
7250000 USD
us-gaap Costs And Expenses
CostsAndExpenses
6341000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6988000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-6121000 USD
us-gaap Interest Expense
InterestExpense
5246000 USD
us-gaap Interest Expense
InterestExpense
8537000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
23000 USD
us-gaap Investment Income Interest
InvestmentIncomeInterest
122000 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
-0 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
197000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-12394000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-24605000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-14733000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-699000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Net Income Loss
NetIncomeLoss
-25307000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14736000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.77
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.57
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
49000 USD
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
629000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
386000 USD
CY2020Q2 us-gaap Assets Current
AssetsCurrent
6335000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
49947000 USD
CY2020Q2 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
2000000 USD
CY2019Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
2000000 USD
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
1998000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
729000 USD
CY2020Q2 us-gaap Goodwill
Goodwill
3813000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
3813000 USD
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4339000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
4118000 USD
CY2020Q2 us-gaap Assets
Assets
70932000 USD
CY2019Q4 us-gaap Assets
Assets
76724000 USD
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
1075000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
194000 USD
CY2020Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1026000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
4536000 USD
CY2020Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
17000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
31000 USD
CY2020Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2037000 USD
CY2019Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
0 USD
CY2020Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
35000 USD
CY2019Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
44000 USD
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4190000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4805000 USD
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73739000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
137565000 USD
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
16431000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
15707000 USD
CY2020Q2 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2019Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
750000 USD
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
15000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
95112000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
158842000 USD
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
1000 USD
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
347000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
285000 USD
CY2020Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
502376000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
419194000 USD
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-526904000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-501597000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-24180000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-82118000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
70932000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
76724000 USD
us-gaap Net Income Loss
NetIncomeLoss
-25307000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14736000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
175000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
132000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
587000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2031000 USD
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
3331000 USD
cdzi Paid In Kind Interest Added To Loan Principal
PaidInKindInterestAddedToLoanPrincipal
4978000 USD
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
712000 USD
cdzi Paid In Kind Interest Added To Lease Liability
PaidInKindInterestAddedToLeaseLiability
622000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-699000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-0 USD
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-12394000 USD
cdzi Gains Losses On Debt Conversion And Extinguishment Of Debt
GainsLossesOnDebtConversionAndExtinguishmentOfDebt
-27000 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
0 USD
us-gaap Induced Conversion Of Convertible Debt Expense
InducedConversionOfConvertibleDebtExpense
197000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1551000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
245000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
51000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
89000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
70000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
243000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
164000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
243000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
243000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
879000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
668000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1516000 USD
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-559000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7019000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-6872000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
2283000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-0 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4712000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
818000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6995000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-818000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3923000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
14642000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
23000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
29000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3900000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14613000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-10114000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6923000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15816000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12691000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5702000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19614000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
-82118000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
38900000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1251000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3923000 USD
CY2020Q1 cdzi Current Period Reclassification Adjustment
CurrentPeriodReclassificationAdjustment
-865000 USD
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-20514000 USD
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
-19687000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
300000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-4793000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
-24180000 USD
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-86240000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
3204000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
122000 USD
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7891000 USD
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-7260000 USD
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-81418000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2251000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
123000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
6752000 USD
CY2019Q2 us-gaap Warrant Down Round Feature Increase Decrease In Equity Amount
WarrantDownRoundFeatureIncreaseDecreaseInEquityAmount
0 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-7476000 USD
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-79768000 USD
us-gaap Net Income Loss
NetIncomeLoss
-25300000 USD
us-gaap Net Income Loss
NetIncomeLoss
-14700000 USD
CY2020Q2 cdzi Working Capital
WorkingCapital
2100000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7000000.0 USD
CY2020Q1 cdzi Required Payment To Acquire Property Available For Purchase Due End Of Fiscal Year
RequiredPaymentToAcquirePropertyAvailableForPurchaseDueEndOfFiscalYear
19000000 USD
CY2019Q3 cdzi Percentage Of Future Quarterly Interest Payments
PercentageOfFutureQuarterlyInterestPayments
0.25 pure
us-gaap Interest Paid Net
InterestPaidNet
715000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
38900000 USD
us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
5766337
CY2020Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
27300000 USD
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5568000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15682000 USD
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
19481000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2019Q4 us-gaap Restricted Cash
RestrictedCash
134000 USD
CY2019Q2 us-gaap Restricted Cash
RestrictedCash
133000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5702000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15816000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
19614000 USD
CY2020Q1 cdzi Debt Instrument Prepayment Premium Percent
DebtInstrumentPrepaymentPremiumPercent
0.07 pure
CY2020Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.01
CY2020Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
2000000.0 USD
CY2020Q1 cdzi Reclassification Of Warrant Liability To Additional Paidin Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidinCapital
900000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1100000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
51000 USD
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
115000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1551000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
245000 USD
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1500000 USD
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
4626000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11442000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3153000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11574000
CY2020Q1 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Period Increase Decrease
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease
865000 USD
CY2020Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1100000 USD
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
51000 USD
CY2020Q2 us-gaap Derivative Liabilities
DerivativeLiabilities
2037000 USD
CY2020Q2 us-gaap Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
2037000 USD

Files In Submission

Name View Source Status
0001437749-20-017083-index-headers.html Edgar Link pending
0001437749-20-017083-index.html Edgar Link pending
0001437749-20-017083.txt Edgar Link pending
0001437749-20-017083-xbrl.zip Edgar Link pending
cdzi-20200630.xsd Edgar Link pending
cdzi-20200630_cal.xml Edgar Link unprocessable
cdzi-20200630_def.xml Edgar Link unprocessable
cdzi-20200630_lab.xml Edgar Link unprocessable
cdzi-20200630_pre.xml Edgar Link unprocessable
cdzi20200630b_10q.htm Edgar Link pending
cdzi20200630b_10q_htm.xml Edgar Link completed
ex_196894.htm Edgar Link pending
ex_196895.htm Edgar Link pending
ex_196896.htm Edgar Link pending
ex_196897.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending